HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Duncan MacKenzie Selected Research

Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)

1/2014VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Duncan MacKenzie Research Topics

Disease

4Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2014 - 08/2011
1Infant Death
01/2014
1Muscular Atrophy (Muscle Atrophy)
09/2013
1Endocarditis
07/2005

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2014 - 09/2013
1Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)IBA
01/2014
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
01/2014
1Human Growth Hormone (Saizen)FDA LinkGeneric
01/2014
1Celecoxib (Celebrex)FDA Link
09/2013
1ProlactinIBA
08/2011

Therapy/Procedure

1Antibiotic Prophylaxis
07/2005